Leptin and the development of obesity and diabetes in Psammomys obesus.
The recently discovered ob gene and its circulating product, leptin, may be critical factors in the control of energy balance. Recent studies in ob/ob mice, which lack circulating leptin, have shown dramatic reductions in food intake and bodyweight after leptin treatment. In addition, studies in both humans with obesity and animal models of obesity have demonstrated hyperleptinemia. Here, we report a longitudinal study examining changes in circulating leptin during the development of obesity and diabetes in Psammomys obesus. Over the 8 weeks of the study, lean animals increased their bodyweight by 154% and leptin levels remained essentially unchanged. In contrast, animals that developed obesity (223% increase in bodyweight), hyperglycemia, and hyperinsulinemia also developed hyperleptinemia between 4 weeks and 8 weeks of age. These results demonstrate that the development of hyperleptinemia is associated with the development of obesity and subsequent metabolic abnormalities.
Collier
G R
GR
School of Nutrition & Public Health, Deakin University, Geelong, Victoria, Australia.
Walder
K
K
Lewandowski
P
P
Sanigorski
A
A
Zimmet
P
P
D000273:Adipose Tissue; D000375:Aging; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D001823:Body Composition; D001835:Body Weight; D003920:Diabetes Mellitus / Q000235:genetics*; D004195:Disease Models, Animal; D004351:Drug Resistance; D004435:Eating; D005849:Gerbillinae / Q000235:genetics*; D007328:Insulin / Q000097:blood; D020738:Leptin; D009765:Obesity / Q000097:blood / Q000235:genetics*; D011506:Proteins / Q000378:metabolism*; D015430:Weight Gain
D001786:Blood Glucose; D007328:Insulin; D020738:Leptin; D011506:Proteins